Regulus Therapeutics
RGLS
#7116
Rank
ยฃ0.41 B
Marketcap
ยฃ6.01
Share price
0.00%
Change (1 day)
424.87%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: ยฃ0.41 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of ยฃ0.41 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ0.41 B421.89%
2024ยฃ80.38 M295.61%
2023ยฃ20.31 M6.54%
2022ยฃ19.07 M-44.02%
2021ยฃ34.06 M-45.84%
2020ยฃ62.89 M340.89%
2019ยฃ14.26 M120.67%
2018ยฃ6.46 M-91.92%
2017ยฃ79.99 M-17.11%
2016ยฃ96.5 M-68.86%
2015ยฃ0.30 B-38.54%
2014ยฃ0.50 B169.35%
2013ยฃ0.18 B34.04%
2012ยฃ0.13 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
ยฃ81.32 B 19,441.68%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ20.34 B 4,788.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ87.56 B 20,940.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ210.97 B 50,594.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ75.88 B 18,133.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
ยฃ41.19 M-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.19 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ29.10 B 6,893.42%๐Ÿ‡บ๐Ÿ‡ธ USA